YPN-005

N/A

Report date: 2022/11/30 17:19:30
NME

Base Information

Drug NameYPN-005
Drug Alias NameYPN-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsBreast NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYungjin Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A